These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2543771)
1. The temperature sensitivity of the Sabin type 3 vaccine strain of poliovirus: molecular and structural effects of a mutation in the capsid protein VP3. Minor PD; Dunn G; Evans DM; Magrath DI; John A; Howlett J; Phillips A; Westrop G; Wareham K; Almond JW J Gen Virol; 1989 May; 70 ( Pt 5)():1117-23. PubMed ID: 2543771 [TBL] [Abstract][Full Text] [Related]
2. An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. Macadam AJ; Ferguson G; Arnold C; Minor PD J Virol; 1991 Oct; 65(10):5225-31. PubMed ID: 1654440 [TBL] [Abstract][Full Text] [Related]
3. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA. Ansardi DC; Luo M; Morrow CD Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243 [TBL] [Abstract][Full Text] [Related]
4. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. Kohara M; Omata T; Kameda A; Semler BL; Itoh H; Wimmer E; Nomoto A J Virol; 1985 Mar; 53(3):786-92. PubMed ID: 2983090 [TBL] [Abstract][Full Text] [Related]
5. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. Bouchard MJ; Lam DH; Racaniello VR J Virol; 1995 Aug; 69(8):4972-8. PubMed ID: 7609067 [TBL] [Abstract][Full Text] [Related]
6. Covariance of lowered capacity to induce interferon in human leukocytes and temperature sensitivity of type 3 poliovirus. Hovi T; Pitkäranta A; Macadam A; Minor P; Almond J J Interferon Res; 1991 Apr; 11(2):105-10. PubMed ID: 1714485 [TBL] [Abstract][Full Text] [Related]
7. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating. Asare E; Mugavero J; Jiang P; Wimmer E; Paul AV J Virol; 2016 Jul; 90(14):6174-6186. PubMed ID: 27076638 [TBL] [Abstract][Full Text] [Related]
8. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. Westrop GD; Wareham KA; Evans DM; Dunn G; Minor PD; Magrath DI; Taffs F; Marsden S; Skinner MA; Schild GC J Virol; 1989 Mar; 63(3):1338-44. PubMed ID: 2536836 [TBL] [Abstract][Full Text] [Related]
9. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses. Mattion NM; Reilly PA; DiMichele SJ; Crowley JC; Weeks-Levy C J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529 [TBL] [Abstract][Full Text] [Related]
10. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704 [TBL] [Abstract][Full Text] [Related]
11. Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees. Macadam AJ; Arnold C; Howlett J; John A; Marsden S; Taffs F; Reeve P; Hamada N; Wareham K; Almond J Virology; 1989 Oct; 172(2):408-14. PubMed ID: 2552655 [TBL] [Abstract][Full Text] [Related]
12. Genetic analysis of the attenuation phenotype of poliovirus type 1. Omata T; Kohara M; Kuge S; Komatsu T; Abe S; Semler BL; Kameda A; Itoh H; Arita M; Wimmer E J Virol; 1986 May; 58(2):348-58. PubMed ID: 3009852 [TBL] [Abstract][Full Text] [Related]
13. Development of candidates for new type 2 and type 3 oral poliovirus vaccines. Kohara M; Abe S; Yoshioka I; Nomoto A Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824 [TBL] [Abstract][Full Text] [Related]
14. Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg. Paul AV; Mugavero J; Yin J; Hobson S; Schultz S; van Boom JH; Wimmer E Virology; 2000 Jun; 272(1):72-84. PubMed ID: 10873750 [TBL] [Abstract][Full Text] [Related]
15. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein. Bräutigam S; Snezhkov E; Bishop DH Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663 [TBL] [Abstract][Full Text] [Related]
16. Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains. Pliaka V; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonika C; Levidiotou-Stefanou S; Krikelis A; Markoulatos P Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1513-23. PubMed ID: 20820837 [TBL] [Abstract][Full Text] [Related]
17. Elongation activity of poliovirus RNA polymerase derived from Sabin type 1 sequence is not temperature sensitive. Baker S; Richards OC; Ehrenfeld E J Gen Virol; 1995 Aug; 76 ( Pt 8)():2081-4. PubMed ID: 7636491 [TBL] [Abstract][Full Text] [Related]
18. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype. Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577 [TBL] [Abstract][Full Text] [Related]
19. Genetic basis of attenuation of the Sabin oral poliovirus vaccines. Minor PD; Macadam AJ; Stone DM; Almond JW Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751 [No Abstract] [Full Text] [Related]
20. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]